European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Monoclonal antibody against human CD30 covalently linked to
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Monoclonal antibody against human CD30 covalently linked to the cytotoxin monomethylauristatin E
| EU orphan designation number: | EU/3/08/595
|
| Active ingredient: | Monoclonal antibody against human CD30 covalently linked to the cytotoxin monomethylauristatin E |
| Indication: | Treatment of anaplastic large cell lymphoma |
| Sponsor: | Seattle Genetics UK Limited
c/o Jordans Limited, 20-22 Bedford Row, London WC1R 4JS , United Kingdom |
| EU Centralised marketing authorisation: | A centralised EU marketing authorisation has been obtained under the name Adcetris on 25/10/2012 with the number EU/1/12/794 |
Public summary of scientific opinion
EPAR
